Evidence map›Paper›PMID 38375812›Full record

ArticleAnnals of medicine2023

Clinical significance of tumor abnormal protein in patients with type 2 diabetes complicated with lung adenocarcinoma

Ke Chen, Xiang Zheng, Jingcheng Hu, Mengjiao Wu, Yingyi Zhou

Open access · goldAbstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in Annals of medicine, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
0.5field-weighted citation impact, top 26% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed, 2 citations in OpenAlex.

  1. Article
  2. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors at 1 institution in 1 country.

Ke ChenThoracic Surgery Department, The First Affiliated Hospital of Soochow University, Suzhou, China.ORCID 0000-0002-4719-491X
Xiang ZhengMedical Examination Center, The First Affiliated Hospital of Soochow University, Suzhou, China.ORCID 0009-0006-4888-9007
Jingcheng HuEndocrine Department, The First Affiliated Hospital of Soochow University, Suzhou, China.ORCID 0009-0002-0377-2623
Mengjiao WuEndocrine Department, The First Affiliated Hospital of Soochow University, Suzhou, China.ORCID 0000-0001-7012-1412
Yingyi ZhouEndocrine Department, The First Affiliated Hospital of Soochow University, Suzhou, China.ORCID 0000-0003-3673-8309
Soochow University · CN

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundTo investigate the application value of tumor abnormal protein in patients with type 2 diabetes mellitus complicated with lung adenocarcinoma MATERIALS AND

methodsA total of 140 patients having type 2 diabetes mellitus complicated with lung adenocarcinoma

resultsThe total cholesterol level was higher in Group A than in Group B (

conclusionTherefore, detecting tumor abnormal protein levels may help diagnose lung adenocarcinoma

Indexed as

Adenocarcinoma in SituDiabetes Mellitus, Type 2NeoplasmsBlood GlucoseCholesterol, HDLCholesterol, LDLClinical RelevanceGlycated HemoglobinHumansLungBlood GlucoseCholesterol, HDLCholesterol, LDLGlycated Hemoglobindiagnosislung adenocarcinoma in situTumor abnormal proteintype 2 diabetes mellitus

Identifiers

PMID38375812
PMCPMC10732207
OpenAlexW4389767469

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.